IP Library Granted Patent US 10,196,375
Granted Patent B2
US 10,196,375 · App. 15/126,336 · Granted Feb 5, 2019

Antifungal compound process

Inventors: William J. Hoekstra (Durham, NC); Christopher M. Yates (Raleigh, NC)
Assignee: MYCOVIA PHARMACEUTICALS, INC.
C07D401/06A61K31/4439A61K45/06C07D213/30C07D213/50C07D257/04C07D403/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,196,375
App. No.
15/126,336
Granted
Feb 5, 2019
Kind
B2
Abstract

The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new methodology for preparing compound 1 and substituted derivatives thereof.

Claims (54)

1. A process to prepare compound 1 or 1a, or a mixture thereof; or a salt of compound 1 or 1a, or a mixture thereof:

the process comprising nitromethylating a compound of formula 15:

to provide a compound of formula 17 or 17a,

or a mixture thereof; and

converting a compound of formula 17 or 17a,

or a mixture thereof, to compound 1 or 1a, or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

2. The process of claim 1 comprising:

(i) reducing a compound of formula 17 or 17a,

or a mixture thereof, to provide a compound of formula 19 or 19a,

or a mixture thereof;

(ii) forming the tetrazole of a compound of formula 19 or 19a,

or a mixture thereof, to provide a compound of formula 9 or 9a,

or a mixture thereof; and

(iii) arylating a compound of formula 9 or 9a,

or a mixture thereof, to provide compound 1 or 1a,

or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

3. A process to prepare compound 1 or 1a, or a mixture thereof; or a salt of compound 1 or 1a, or a mixture thereof:

the process comprising:

(i) arylating a compound of formula 15,

to provide ketone 16,

(ii) nitromethylating ketone 16,

to provide nitro-alcohol 18 or 18a,

or a mixture thereof;

(iii) reducing nitro-alcohol 18 or 18a,

or a mixture thereof, to provide amino-alcohol 20 or 20a,

or a mixture thereof; and

(iv) forming the tetrazole of amino-alcohol 20 or 20a,

or a mixture thereof, to provide compound 1 or 1a,

or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

4. The process of claim 1 comprising:

(i) arylating a compound of formula 17 or 17a,

or a mixture thereof, to provide nitro-alcohol 18 or 18a,

or a mixture thereof;

(ii) reducing nitro-alcohol 18 or 18a,

or a mixture thereof, to provide amino-alcohol 20 or 20a,

or a mixture thereof;

(iii) forming the tetrazole of amino-alcohol 20 or 20a,

or a mixture thereof, to provide compound 1 or 1a,

or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

5. The process of claim 1 comprising:

(i) reducing a compound of formula 17 or 17a,

or a mixture thereof, to provide a compound of formula 19 or 19a,

or a mixture thereof;

(ii) arylating a compound of formula 19 or 19a,

or a mixture thereof, to provide amino-alcohol 20 or 20a,

and

(iii) forming the tetrazole of amino-alcohol 20 or 20a,

or a mixture thereof, to provide compound 1 or 1a,

or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

Assignments (3)
CHANGE OF NAME Recorded Mar 28, 2018
From: VIAMET PHARMACEUTICALS (NC), INC.
To: MYCOVIA PHARMACEUTICALS, INC.
Reel/Frame 045759/0728 →
CHANGE OF NAME Recorded Jan 2, 2018
From: VIAMET PHARMACEUTICALS, INC.
To: VIAMET PHARMACEUTICALS (NC), INC.
Reel/Frame 044978/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2016
From: HOEKSTRA, WILLIAM J.; YATES, CHRISTOPHER M.
To: VIAMET PHARMACEUTICALS, INC.
Reel/Frame 039999/0385 →
Continuity (2)
Provisional Application 61955565 · Mar 19, 2014
Related Publication 20170081310A1 · Mar 23, 2017